N+1 Singer | Institutional Broker and Corporate Advisor

September 22, 2017

Life Science Dinner at the Don

The Life Science team at N+1 Singer (analysts Jens Lindqvist and Sheena Berry, Brough Ransom in specialist sales and Aubrey Powell representing corporate finance) hosted a dinner last night for companies and investors in...

September 22, 2017

Realm Therapeutics: Placing of £19.3M to advance drug development programmes

Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on leveraging its proprietary immunomodulatory technology, is pleased to announce that it has successfully secured funding commitments to raise gross proceeds of approximately...

September 20, 2017

Video: the London Stock Exchange and N+1 Singer discuss IPOs

Tim Cockroft is founder and CEO of N+1 Singer; James Clark, with 20 years’ experience in and around the funding of tech businesses, is currently the Head of Tech and Life Sciences in Primary...

This year, N+1 Singer celebrates 10 years of raising equity for the growth of the UK's small and mid-cap sector.

We are a partnership and as such can take a long-term view to deliver our clients strategies.

We have advised on more than 120 IPOs, secondary offerings and block trades, raising £2.5bn for 83 companies since 2013.

Technology

Life Sciences

Technology

Technology

Consumer

Chemicals

Financials

Investment Funds

Investment Funds

Technology

Support Services

Capital Goods

Consumer

Life Sciences

Investment Funds

Technology

Support Services

Retail

Investment Funds

Life Sciences

Financials

Consumer

Technology

Life Sciences

Financials

Technology

Support Services

Technology

Technology

Life Sciences

Investment Funds

Life Sciences

Chemicals

Life Sciences

Capital Goods

Retail

Technology

Life Sciences

Media

Media

Support Services

Technology

Investment Funds

Financials

Support Services

Financials

Investment Funds

Technology

Technology

Investment Funds

Life Sciences

Chemicals

Support Services

Technology

Media

Financials

Technology

Support Services

Retail

Consumer

Investment Funds

Technology

Life Sciences

Technology

Media

Investment Funds

Life Sciences

Investment Funds

Life Sciences

Financials

Investment Funds

Technology

Technology

Investment Funds

Capital Goods

Life Sciences

Retail

Support Services

Technology

Financials

Support Services

Support Services

Investment Funds

Support Services

Capital Goods

Investment Funds

Media

Capital Goods